Discover how DFIN helped Virax Biolabs, a newly public biotech company focused on the detection of immune responses to viral diseases, streamline their SEC filing process and boost productivity with ActiveDisclosure.
How We Helped an Innovative Biotech Company Drive SEC Filing Efficiencies.
To learn more, view the
case study
below.
